CIK 0001101026
- Non-accelerated filer
- Smaller reporting company
Zivo Bioscience, Inc.
Sign in to watch- Ticker
- ZIVO
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870699977
- Phone
- +1 248-452-9866
- Business address
- 21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS, MI, 48304
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC, WESTERN GLORY HOLE INC
- 4 Open-market buy Director bought 18,000 shares at $0.15 ($2,700)
- 4 Open-market buy Director bought 102,000 shares at an average $0.13 ($13,350)
- 4 Open-market buy Director bought 85,000 shares at $0.12 ($10,200)
- 4 Open-market buy Director bought 15,000 shares at $0.11 ($1,650)
- 4 Open-market buy Director bought 10,000 shares at an average $0.13 ($1,250)
- 4 Open-market buy Director bought 40,000 shares at $0.10 ($4,000)
- 4 Open-market buy 10% owner bought 13,088,129 shares at $0.10 ($1,308,813)
- 4 Open-market buy Director bought 163,000 shares at an average $0.09 ($15,190)
- 4 Open-market buy Director bought 116,000 shares at $0.11 ($12,760)
- 4 Open-market buy Director bought 60,000 shares at an average $0.12 ($7,100)
- 4 Open-market buy Director bought 116,000 shares at an average $0.09 ($10,650)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 3/A Insider 3/A
- 4 Open-market buy Director bought 74,000 shares at an average $0.07 ($5,360)
- 4 Open-market buy Director bought 103,000 shares at an average $0.09 ($9,490)
- 4 Open-market buy Director bought 125,000 shares at an average $0.09 ($11,430)
Page 7 of 12 · 239 filings